Literature DB >> 24026002

[Amebic liver abscess and late recurrence with no travel in an endemic area].

C Guyon1, E Greve, B Hag, M Cuilleron, R Jospe, C Nourrisson, H Raberin, R Tran Manh Sung, J G Balique, P Flori.   

Abstract

Amebic liver abscess is the main complication of amebic dysentery. Recurrences after treatment and apparent healing are very uncommon. The purpose of this report is to describe the case of a patient with a very late relapse of an amebic liver abscess, 10 years after the first episode. This recurrence seems due to an incomplete initial treatment. This case illustrates the reason for and importance of complying with the current therapeutic strategy: nitroimidazole followed by a luminal agent to eradicate intestinal amebic colonization.

Entities:  

Keywords:  Entamœba histolytica; liver abcess; luminal agent; recurrence

Mesh:

Substances:

Year:  2013        PMID: 24026002     DOI: 10.1684/mst.2013.0189

Source DB:  PubMed          Journal:  Med Sante Trop        ISSN: 2261-3684


  3 in total

1.  Ponatinib, Lestaurtinib, and mTOR/PI3K Inhibitors Are Promising Repurposing Candidates against Entamoeba histolytica.

Authors:  Monica M Kangussu-Marcolino; Upinder Singh
Journal:  Antimicrob Agents Chemother       Date:  2021-12-06       Impact factor: 5.938

2.  First case of amebic liver abscess 22 years after the first occurrence.

Authors:  Benoît Nespola; Valérie Betz; Julie Brunet; Jean-Charles Gagnard; Yves Krummel; Yves Hansmann; Thierry Hannedouche; Daniel Christmann; Alexander W Pfaff; Denis Filisetti; Bernard Pesson; Ahmed Abou-Bacar; Ermanno Candolfi
Journal:  Parasite       Date:  2015-06-18       Impact factor: 3.000

3.  Recurrent amebic liver abscesses over a 16-year period: a case report.

Authors:  D Creemers-Schild; P J J van Genderen; L G Visser; J J van Hellemond; P J Wismans
Journal:  BMC Res Notes       Date:  2016-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.